ORGO
Organogenesis Holdings Inc.
A regenerative-medicine company that grows living skin and tissue grafts to help wounds heal. Its best-known product, Apligraf, was the first living cell-based skin substitute approved by the U.S. Food and Drug Administration, and its PuraPly line treats chronic wounds like diabetic ulcers. Founded in 1985 in Cambridge, Massachusetts, the company's name reflects its mission of growing organs and tissues in the lab.
CUSIP: 68621F102HealthcareUS1 holder
Total Value
$28.6K
Total Shares
10.6K
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
